Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-07-16 16:31:12 ET · period of report 2026-07-15 · accession 0001061983-26-000080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-16 16:31 | 2026-07-15 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $82.62 | +272 | 78.4K | +0.3% | +$22.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-15 | A | A | 272 | $82.62 | 78,360 | D | — | — | (F1) Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant. |